PRIMARY STUDY
Cannabinoids as a Natural Alternative for the Management of Neuropathic Pain: A Systematic Review of Randomized Placebo-Controlled Trials
Key Findings: This systematic review finds that cannabinoids provided significant relief from chronic pain, compared to placebo. Transdermal cannabidiol (CBD) leads to a more pronounced reduction in sharp pain. Minimal to no side effects were recorded.
Type of Study: Clinical Meta-analysis
Study Sample Size: 5
Study Result: Positive
Research Location(s): Mauritius
Year of Pub: 2024
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Route of Administration: Oral (Ingestion), Sublingual/Oromucosal
Cannabinoid Ratio: (THC : CBD) 0 : 0 
Clinical Relevance: Cannabinoids provide significant relief from chronic pain.
Adverse Events: Minimal to no side effects were recorded.
Citation: Reechaye D, et al. Cannabinoids as a Natural Alternative for the Management of Neuropathic Pain: A Systematic Review of Randomized Placebo-Controlled Trials. Cureus. 2024; 16:e70021. doi: 10.7759/cureus.70021
Authors: Reechaye D, Perrine ALA, Jahajeeah Y, Dookhee F, Robinson J, Banerjee I
